Capital Partners has completed a control investment in MicroCare, in partnership with the company’s co-founder and senior management.
Following this deal, which took place on 28th May, MicroCare will continue to operate under the MicroCare, Sticklers, and MicroCare Medical brands.
Sarah Paquet, vice president at Capital Partners, commented: “We closed this investment in the midst of the Covid-19 crisis as the company has proven to be a strong, recession-resistant essential business, which should benefit from a growing global focus on cleanliness and increasing importance on telecom infrastructure.”
Tom Tattersall, former MicroCare COO, who will assume the role of MicroCare CEO, said: “The sale of MicroCare was a very lengthy process to ensure we found the right fit for our company, our employees and our customers. We are pleased that Capital Partners recognises the strengths of the MicroCare business as well as its future potential.
“With Capital Partners’ on-going support, we are well-positioned to continue our sustainable, profitable growth. With further investments in product development, technology and distribution infrastructure, we remain committed to delivering a broad range of critical cleaning solutions and the value-added technical expertise and lab-support our distributors and end-users have come to expect from us.”
Ed Tan, managing director of Capital Partners, added: “MicroCare is a leader in multiple, highly-attractive industrial end markets.
“MicroCare is a perfect fit with our approach of partnering with great managers and investing in a business with strong organic growth potential and attractive strategic acquisition opportunities.”